Controlled Study to Assess the Efficacy and Safety of S-Ibuprofen Topical Gel 5% (AP0302) in the Treatment of DOMS

NCT03852459 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

251

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain, Acute

Interventions

DRUG: S-Ibuprofen
DRUG: Vehicle

Sponsor

Aponia Laboratories, Inc.